Literature DB >> 15905405

Embryonic stem cell differentiation: emergence of a new era in biology and medicine.

Gordon Keller1.   

Abstract

The discovery of mouse embryonic stem (ES) cells >20 years ago represented a major advance in biology and experimental medicine, as it enabled the routine manipulation of the mouse genome. Along with the capacity to induce genetic modifications, ES cells provided the basis for establishing an in vitro model of early mammalian development and represented a putative new source of differentiated cell types for cell replacement therapy. While ES cells have been used extensively for creating mouse mutants for more than a decade, their application as a model for developmental biology has been limited and their use in cell replacement therapy remains a goal for many in the field. Recent advances in our understanding of ES cell differentiation, detailed in this review, have provided new insights essential for establishing ES cell-based developmental models and for the generation of clinically relevant populations for cell therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15905405     DOI: 10.1101/gad.1303605

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  401 in total

Review 1.  Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.

Authors:  Emanuela Binello; Isabelle M Germano
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

Review 2.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 3.  Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment.

Authors:  Yubing Sun; Christopher S Chen; Jianping Fu
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

Review 4.  Epigenetic landscape of pluripotent stem cells.

Authors:  Ji Woong Han; Young-sup Yoon
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

5.  Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Authors:  Han Qin; Kathryn Blaschke; Grace Wei; Yuki Ohi; Laure Blouin; Zhongxia Qi; Jingwei Yu; Ru-Fang Yeh; Matthias Hebrok; Miguel Ramalho-Santos
Journal:  Hum Mol Genet       Date:  2012-01-27       Impact factor: 6.150

6.  Characterization of hemangioblast in umbilical arteries of mid-gestation mouse embryos.

Authors:  Weixi Niu; He Huang; Liangyu Zhao; Zhuan Li; Wenyan He; Bing Liu; Longgui Li; Jiaxiang Xiong
Journal:  Int J Hematol       Date:  2012-04-29       Impact factor: 2.490

7.  Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiation.

Authors:  Xiaofeng Zheng; Raluca Dumitru; Brad L Lackford; Johannes M Freudenberg; Ajeet P Singh; Trevor K Archer; Raja Jothi; Guang Hu
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

8.  Differentiation of oligodendrocytes from mouse induced pluripotent stem cells without serum.

Authors:  Sachiyo Misumi; Ruriko Nishigaki; Yoshitomo Ueda; Yoko Watanabe; Yuko Shimizu; Akimasa Ishida; ChaGyun Jung; Hideki Hida
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

9.  Thyrotropin-independent induction of thyroid endoderm from embryonic stem cells by activin A.

Authors:  Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2008-12-12       Impact factor: 4.736

10.  Inhibition of master transcription factors in pluripotent cells induces early stage differentiation.

Authors:  Debojyoti De; Myong-Ho Jeong; Young-Eun Leem; Dmitri I Svergun; David E Wemmer; Jong-Sun Kang; Kyeong Kyu Kim; Sung-Hou Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.